 |
|
German researchers make significant strides in identifying cause of bacterial infections
April 23, 2009Several bacterial pathogens use toxins to manipulate human host cells, ultimately disturbing cellular signal transduction. Until now, however, scientists have been able to track down only a few of the proteins that interact with bacterial toxins in infected human cells. Now, researchers of the Max Planck Institute of Biochemistry in Martinsried and the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch in Germany have identified 39 interaction partners of these toxins, using novel technology which allowed them to screen for large numbers of proteins simultaneously (Cell Host & Microbe, Vol. 5, Issue 4, 397-403)*.
Many bacteria inject toxins into human cells using a secretion system that resembles a molecular syringe. Within the host cell, some of these toxins are activated in such a way that they can manipulate important cellular signaling pathways. In healthy cells, these signals serve to regulate metabolism or cell division, among other things. By manipulating the signals, bacteria can abuse the cell machinery of the human host in order to spread and survive.
Applying a method developed by Professor Matthias Mann of the MPI, the scientists succeeded for the first time in systematically investigating the cellular target sites of the bacterial toxins. "Surprisingly, the toxins are not optimally adapted to the structures of human proteins," Dr. Matthias Selbach of MDC explained. While binding relatively weakly to individual human proteins, they are able to influence several different proteins simultaneously. "A single bacterial toxin seems to function like a master key that can access different host cell proteins in parallel", Dr. Selbach said. "Perhaps it is due to this strategy that bacteria are able to attack very different cells and, thus, to increase their survival chances in the host."
Dr. Selbach hopes that these basic research findings will help to improve the treatment of bacterial infections in the future. Instead of nonspecific antibiotic therapy, new drugs could target the signaling mechanisms which are disrupted by the bacterial toxins.
Helmholtz Association of German Research Centres
Dr. Selbach hopes that these basic research findings will help to improve the treatment of bacterial infections in the future. Instead of nonspecific antibiotic therapy, new drugs could target the signaling mechanisms which are disrupted by the bacterial toxins.
Helmholtz Association of German Research Centres
Bacterial Toxins Current Events and Bacterial Toxins News RSSType of vitamin B1 could treat common cause of blindness
University of Texas Medical Branch at Galveston researchers have discovered that a form of vitamin B1 could become a new and effective treatment for one of the world's leading causes of blindness.
NYU scientists discover dangerous new method for bacterial toxin transfer
Scientists have discovered a new way for bacteria to transfer toxic genes to unrelated bacterial species, a finding that raises the unsettling possibility that bacterial swapping of toxins and other disease-aiding factors may be more common than previously imagined.
Researchers discover how infectious bacteria can switch species
Scientists from the Universities of Bath and Exeter have developed a rapid new way of checking for toxic genes in disease-causing bacteria which infect insects and humans.
Scripps scientists studying sepsis in mice find potential drug targets for deadly disease
"We have identified a key connection of signaling pathways in the cascade of events leading to sepsis. This defines a crucial point where the immune system spirals out of control to cause severe sepsis and where there is an opportunity for therapeutic intervention," says Scripps Research Professor Wolfram Ruf, who led the research with his postdoctoral fellow Frank Niessen.
Research suggests new treatment suitable for all patients
New research at Wake Forest University Baptist Medical Center suggests that a three-drug cocktail may one day improve outcomes in patients with glioblastoma multiforme (GBM), a type of brain tumor with a dismal prognosis.
Leading cause of death in 'preemies' might be controlled by resetting a molecular switch
Blocking signals from a key molecular receptor that normally switches on the intestine's immune response but instead becomes too intense in the presence of stress and toxins may help reverse necrotizing enterocolitis (NEC), a leading cause of death in premature newborns.
New designer toxins kill Bt-resistant insect pests
A new way to combat resistant pests stems from discovering how the widely used natural insecticide Bt kills insects.
Ozone shuts down early immune response in lungs and body
As policy makers debate what levels of ozone in the air are safe for humans to breathe, studies in mice are revealing that the inhaled pollutant impairs the body's first line of defense, making it more susceptible to subsequent foreign invaders, such as bacteria.
Toxic shock: immune system's anthrax link
Human immune proteins crucial for fighting cancer, viruses and bacterial infections belong to an ancient and lethal toxin family previously only found in bacteria, Australian researchers have found.
Most widely used organic pesticide requires help to kill
The world's most widely used organic insecticide, a plucky bacterium known as Bacillus thuringiensis or Bt for short, requires the assistance of other microbes to perform its insect-slaying work, a new study has found.
More Bacterial Toxins Current Events and Bacterial Toxins News Articles
 |
Bacterial Toxins and Virulence Factors in Disease (Volume 8) (Handbook of Natural Toxins) by Moss (Author) Detailing the diverse ways bacterial toxins subvert cellular metabolism and signalling, this state-of-the-art reference describes the structure and function of bacterial toxins and presents a comprehensive review of virulence factors -- providing the latest information concerning cell physiology and biochemistry, as well as new toxin tools for experimental studies and clinical therapy. |
|
Ortho Molecular Saccharomyces Boulardii - 60 Capsules by Ortho Molecular Saccharomyces boulardii is a non-pathogenic probiotic yeast. S.boulardii has been well studied for its use in the prevention of gastrointestinal disturbances often associated with the use of antibiotics. S.boulardii has also been used in clinical trials in patients with irritable bowel disorders. Saccharomyces boulardii has been found to exert many beneficial effects in humans and acts in two principle ways: first by inhibiting some bacterial toxins or their effects; and secondly by having direct effects on the intestinal mucosa. | |
 |
The Comprehensive Sourcebook of Bacterial Protein Toxins, Third Edition by Joseph E. Alouf (Editor), Michel R. Popoff (Editor) Bacterial toxins play an important role in infectious diseases. Several are amongst the most potent biological agents known to man. Cholera, pertussis, botulinum, clostridium and tetanus toxins are all produced by bacteria. In many cases, it is the toxin produced and not the infectious agent itself that causes pathology. Botulinum toxin has now of course found clinical application as botox, and anthrax, and other toxins, have potentially devastating effects if misused as an agent of biological terror. This book describes the major achievements and discoveries relevant to bacterial protein toxins since the turn of the new century, illustrated by the discovery of more than fifty novel toxins (many of them identified through genome screening). The establishment of the three-dimensional... |
 |
Toxin: The Cunning of Bacterial Poisons by Alistair J. Lax (Author) What do the following have in common: the promise of Botox as the key to everlasting youthful looks; E. coli O157 hamburger disease; a mysterious illness which killed 35 heroin users in 2000; and the assassination by poisoned umbrella-tip of a Bulgarian dissident in the 1970s? The answer is that all of these are caused by bacterial toxins, the powerful biological poisons released by bacteria and some plants. In Toxin, Alistair Lax reveals the panoply of ways in which bacterial toxins overcome the defenses of our cells. He explains how they work, how they are so successful in causing major diseases, the terrible human impact they have had, and how apparently 'new' diseases arise from them. He also discusses how we can combat toxins, and how we can harness their actions for beneficial... |
![Toxin - A Novel of Bacterial Poisoning and Corporate Malevolence (A Medical Thriller) (UNABRIDGED) [8 Audio Cassettes/12 Hours]](http://ecx.images-amazon.com/images/I/51bVRlH2jKL._SL160_.jpg) |
Toxin - A Novel of Bacterial Poisoning and Corporate Malevolence (A Medical Thriller) (UNABRIDGED) [8 Audio Cassettes/12 Hours] by Robin Cook (Author) Bacterial contamination, product tampering and the evil of big business in this latest Robin Cook thriller. Dr. Kim Reggis, one of the country's top cardiac surgeons, finds himself ill-equipped to deal with a medical catastrophe involving his own daughter, Becky. Newly divorced, Reggis takes Becky to her favorite fast-food restaurant. After the meal, she sickens and dies. Concentrated with fury, anger and grief, Reggis vows to find out how and why. A trail of deadly evidence leads from the slaughterhouse floor to the corporate boardroom. Aided in his quest by his ex-wife, Tracy, Reggis races against time before more people are poisond by the E. coli bacteria. Reggis and Tracy ultimately learn the grim truth that fuels today's fears and tomorrow's headlines- and rediscover the reasons why... |
 |
Special Issue on Emerging Bacterial Toxins (Reviews of Physiology, Biochemistry and Pharmacology) by Klaus Aktories (Editor), Ingo Just (Editor) Albert-Ludwigs-Univ., Freiburg, Germany. Text offers in-depth reviews of current developments and trends. Focuses on key points in an attempt to highlight the advancements in these fields. More than 57 full-color and halftone illustrations and graphs included. |
|
Microbial Toxins: Bacterial Protein Toxins v. 1 by Academic Press Inc.,U.S. (Publisher) | |
 |
Bacterial Protein Toxins (Handbook of Experimental Pharmacology) (Volume 145) by K. Aktories (Editor), I. Just (Editor) In recent years remarkable progress has been accomplished with respect to our knowledge about bacterial protein toxins. This refers especially to structural aspects of protein toxins but also holds true for genetics, molecular biology and biochemical mechanisms underlying the action of toxins. This volume covers the very current and exciting aspects of up-to-date bacterial toxicology and comprehensively reviews the most important bacterial protein toxins such as the intracellular acting toxins which exhibit enzyme activity, as well as those toxins that interact with cell plasma membranes by damaging the membranes (pore formation) or stimulating cell receptors (superantigens). This is the most current reference work on these important bacterial protein toxins, which are presented from the... |
 |
Trafficking of Bacterial Toxins by Catharine B. Saelinger (Author) This work represents a compilation of studies on the entry into and subsequent processing of several bacterial and plant toxins in mammalian cells. Emphasis is placed on the close parallel of mammalian cell processing of toxic proteins and physiologically essential ligands. This easy-to-read book includes chapters which review the structures of the toxins. It compares and contrasts the trafficking of pseudomonas and diphtheria toxins. It also discusses anthrax toxin and the clostridial neurotoxins. |
|
Bacterial Toxins (Aspects of Microbiology 2) by J. Stephen (Author), R. A. Pietrowski (Author) |
| © 2009 BrightSurf.com |